Multiple law firms are investigating Alignment Healthcare after a former executive alleged expense misclassification inflated Adjusted EBITDA, with the stock falling $4.02 on July 8.
Law firms are investigating potential securities violations at Alignment Healthcare, Inc. after a former executive filed a whistleblower lawsuit alleging the company manipulated its finances by misclassifying operating expenses as capital expenditures. The executive, who worked at Alignment from 2019 to 2025 and most recently served as chief transformation officer, alleged the practice boosted the company’s adjusted EBITDA for 2024 and 2025 and inflated performance metrics tied to the stock price and executive compensation. Alignment Healthcare shares fell $4.02, or about 17%, from $24.05 on July 7, 2026 to close at $20.03 on July 8. Kirby McInerney LLP said no lawsuit has been filed by the firm at this stage and that its investigation is ongoing.